Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Elizabeth McFarland

Concepts (356)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections
43
2023
2440
2.730
Why?
HIV-1
23
2023
764
2.680
Why?
Respiratory Syncytial Virus Vaccines
6
2022
24
2.460
Why?
Respiratory Syncytial Virus Infections
6
2022
97
2.290
Why?
Respiratory Syncytial Virus, Human
6
2022
60
2.230
Why?
Anti-Retroviral Agents
12
2023
207
1.820
Why?
Infectious Disease Transmission, Vertical
15
2023
150
1.760
Why?
Viral Proteins
3
2020
280
1.690
Why?
HIV Antibodies
10
2023
49
1.660
Why?
Antibodies, Viral
7
2022
519
1.090
Why?
Antibodies, Neutralizing
7
2022
222
0.980
Why?
Antibodies, Monoclonal
5
2021
1236
0.800
Why?
Pregnancy Complications, Infectious
7
2016
284
0.790
Why?
Gene Deletion
2
2020
351
0.760
Why?
AIDS Vaccines
7
2018
41
0.710
Why?
Atazanavir Sulfate
2
2017
40
0.660
Why?
Breast Feeding
3
2023
366
0.660
Why?
HIV Protease Inhibitors
2
2017
60
0.650
Why?
Ritonavir
2
2017
69
0.640
Why?
Anti-HIV Agents
9
2023
660
0.630
Why?
Vaccines, Attenuated
6
2022
113
0.600
Why?
Infant, Newborn
20
2023
5032
0.570
Why?
Nelfinavir
1
2016
8
0.530
Why?
Vaccination
5
2020
1198
0.520
Why?
Lyme Disease
1
2016
32
0.520
Why?
Syncope
1
2016
38
0.520
Why?
Lopinavir
1
2016
29
0.520
Why?
Patient Dropouts
1
2016
66
0.510
Why?
Infant
28
2023
7922
0.510
Why?
Bradycardia
1
2016
47
0.510
Why?
Health Resources
1
2016
119
0.480
Why?
Infant, Newborn, Diseases
1
2016
104
0.460
Why?
HIV
5
2014
205
0.440
Why?
Patient Compliance
2
2018
523
0.430
Why?
HIV Envelope Protein gp120
5
2017
55
0.410
Why?
Immunogenicity, Vaccine
4
2021
25
0.400
Why?
Child
35
2023
18340
0.400
Why?
CD4-Positive T-Lymphocytes
2
2017
960
0.380
Why?
Virus Replication
4
2020
392
0.380
Why?
T-Lymphocytes, Cytotoxic
4
2005
154
0.370
Why?
Humans
65
2023
113531
0.360
Why?
Female
42
2023
59115
0.340
Why?
Male
34
2021
55112
0.300
Why?
Viral Load
9
2017
403
0.300
Why?
Adolescent
25
2023
17724
0.300
Why?
HIV Seropositivity
2
2023
109
0.290
Why?
Double-Blind Method
3
2020
1643
0.290
Why?
RNA, Viral
8
2023
562
0.270
Why?
Antibodies, Bacterial
2
2018
119
0.260
Why?
Dyslipidemias
2
2017
153
0.250
Why?
Antiretroviral Therapy, Highly Active
6
2017
254
0.240
Why?
Immunoglobulin G
3
2022
760
0.240
Why?
Young Adult
12
2021
10400
0.230
Why?
Immunoenzyme Techniques
1
2005
191
0.230
Why?
Viremia
3
2011
122
0.230
Why?
Gene Products, gag
2
1994
36
0.220
Why?
Child, Preschool
20
2022
9093
0.220
Why?
Pregnancy
10
2023
5490
0.210
Why?
Drug Resistance, Viral
2
2016
99
0.200
Why?
CD4 Lymphocyte Count
4
2017
253
0.190
Why?
Growth Differentiation Factor 15
1
2021
33
0.190
Why?
Half-Life
1
2021
140
0.190
Why?
T-Lymphocytes
2
2009
1725
0.190
Why?
Mitochondrial Diseases
1
2021
76
0.180
Why?
Immunization Schedule
2
2018
183
0.180
Why?
Drug Therapy, Combination
4
2017
944
0.180
Why?
Lymphocyte Activation
4
2017
1032
0.180
Why?
Fibroblast Growth Factors
1
2021
161
0.180
Why?
RNA, Small Untranslated
1
2020
15
0.170
Why?
Cytokines
2
2021
1795
0.170
Why?
env Gene Products, Human Immunodeficiency Virus
2
2017
16
0.170
Why?
Hydrophobic and Hydrophilic Interactions
1
2020
176
0.160
Why?
Body Temperature
1
2020
176
0.160
Why?
Insulin Resistance
3
2019
1068
0.160
Why?
Squalene
2
2017
5
0.160
Why?
Point Mutation
1
2020
214
0.160
Why?
Immunologic Memory
2
2021
313
0.160
Why?
Haemophilus Vaccines
2
2018
27
0.150
Why?
Immunocompromised Host
2
2000
190
0.150
Why?
Metabolic Syndrome
1
2021
317
0.150
Why?
Interleukin-12
1
1998
110
0.150
Why?
Darunavir
1
2017
16
0.150
Why?
Mycobacterium Infections, Nontuberculous
2
2012
326
0.140
Why?
Dose-Response Relationship, Drug
1
2021
1822
0.140
Why?
Interferon-gamma
5
2012
710
0.140
Why?
Immunoglobulin A
2
2017
166
0.140
Why?
Therapeutic Equipoise
1
2017
2
0.140
Why?
Antibody Formation
1
2018
265
0.140
Why?
High-Throughput Screening Assays
1
2018
123
0.140
Why?
Uganda
1
2017
69
0.140
Why?
Lymphopoiesis
1
2017
24
0.140
Why?
Receptors, CCR5
1
2017
54
0.140
Why?
Adult
15
2023
30245
0.140
Why?
CD4-CD8 Ratio
1
2016
19
0.130
Why?
HIV-Associated Lipodystrophy Syndrome
1
2016
11
0.130
Why?
Mothers
3
2017
651
0.130
Why?
Adoption
1
2016
32
0.130
Why?
Virus Latency
1
2016
79
0.130
Why?
Continuity of Patient Care
1
2018
252
0.120
Why?
Early Diagnosis
1
2016
218
0.120
Why?
Chickenpox Vaccine
1
2015
69
0.120
Why?
Body Height
2
2017
180
0.120
Why?
Disease Susceptibility
1
2017
314
0.120
Why?
Gene Products, env
1
1994
7
0.120
Why?
Developing Countries
1
2016
231
0.120
Why?
Haemophilus influenzae type b
1
2014
10
0.120
Why?
Bacterial Capsules
1
2014
28
0.120
Why?
Antibody Affinity
1
2014
51
0.120
Why?
Retrospective Studies
8
2023
12504
0.120
Why?
Chickenpox
1
2015
93
0.120
Why?
Acquired Immunodeficiency Syndrome
2
2000
212
0.120
Why?
Parotitis
1
2014
6
0.110
Why?
Lipids
1
2017
558
0.110
Why?
Intestines
1
2017
324
0.110
Why?
Puberty, Delayed
1
2013
4
0.110
Why?
Mitochondria
2
2021
735
0.110
Why?
Vaccines
1
2018
372
0.110
Why?
Patient Selection
1
2017
625
0.110
Why?
RNA-Directed DNA Polymerase
1
1993
33
0.110
Why?
Cohort Studies
7
2021
4880
0.110
Why?
Mycobacterium chelonae
1
1993
8
0.100
Why?
Cardiovascular Diseases
2
2016
1725
0.100
Why?
Child Development
1
2017
381
0.100
Why?
Pediatric Obesity
1
2019
490
0.100
Why?
Cell Movement
1
2017
852
0.100
Why?
Bone Density
1
2016
432
0.100
Why?
Prospective Studies
4
2017
6189
0.100
Why?
Lamivudine
3
2023
58
0.100
Why?
Clinical Trials as Topic
1
2017
922
0.100
Why?
United States
9
2023
12137
0.100
Why?
Body Weight
2
2017
853
0.100
Why?
STAT1 Transcription Factor
1
2012
60
0.100
Why?
Body Fat Distribution
1
2011
45
0.100
Why?
Epitopes
2
2022
430
0.090
Why?
Mycobacterium avium Complex
1
2012
89
0.090
Why?
Research Design
1
2017
916
0.090
Why?
Biomedical Research
1
2017
581
0.090
Why?
Exercise
1
2021
1617
0.090
Why?
Prenatal Exposure Delayed Effects
1
2016
453
0.090
Why?
Respiratory Tract Infections
1
2014
320
0.090
Why?
Interleukin-2
2
2003
412
0.080
Why?
Biomarkers
4
2021
3389
0.080
Why?
Algorithms
1
2016
1462
0.080
Why?
Phenotype
1
2017
2754
0.080
Why?
Freezing
1
2009
83
0.080
Why?
Blood
1
2009
93
0.080
Why?
Age Factors
4
2019
2875
0.080
Why?
Staff Development
1
2009
39
0.080
Why?
Specimen Handling
1
2009
152
0.070
Why?
Enzyme-Linked Immunosorbent Assay
2
2021
783
0.070
Why?
Lymphocyte Subsets
2
2009
79
0.070
Why?
Adipose Tissue
1
2011
537
0.070
Why?
Faculty
1
2009
123
0.070
Why?
Withholding Treatment
1
2008
66
0.070
Why?
Enterovirus A, Human
1
2007
12
0.070
Why?
Leukocytes, Mononuclear
3
2013
487
0.070
Why?
Vaccines, Synthetic
3
2005
124
0.070
Why?
Central Nervous System Viral Diseases
1
2007
63
0.070
Why?
Polymerase Chain Reaction
4
2011
984
0.070
Why?
Academic Medical Centers
1
2009
406
0.070
Why?
DNA, Viral
2
2000
345
0.060
Why?
Cytotoxicity, Immunologic
2
1998
187
0.060
Why?
Colorado
3
2023
4061
0.060
Why?
Cell Line
3
2012
2581
0.060
Why?
Enterovirus Infections
1
2007
160
0.060
Why?
C-Reactive Protein
2
2021
360
0.060
Why?
Follow-Up Studies
3
2021
4384
0.060
Why?
Isoantigens
1
1984
14
0.060
Why?
Disease Outbreaks
1
2007
305
0.060
Why?
Immunity, Cellular
1
2006
246
0.060
Why?
Linear Models
2
2020
767
0.060
Why?
Comorbidity
2
2021
1443
0.060
Why?
Risk Factors
4
2021
8606
0.060
Why?
Thymus Gland
1
1984
291
0.050
Why?
Cote d'Ivoire
1
2023
8
0.050
Why?
Tablets
1
2023
35
0.050
Why?
Regression Analysis
2
2021
932
0.050
Why?
Immunophenotyping
2
1994
272
0.050
Why?
Respiratory Syncytial Viruses
1
2022
46
0.050
Why?
Zidovudine
2
2015
77
0.050
Why?
Cough
1
2022
108
0.050
Why?
Emtricitabine
1
2023
146
0.050
Why?
Pyridones
1
2023
122
0.050
Why?
Lung
1
2014
3497
0.050
Why?
Polysorbates
2
2017
35
0.050
Why?
Tenofovir
1
2023
203
0.050
Why?
Cross-Sectional Studies
3
2021
4400
0.050
Why?
Clinical Trials, Phase I as Topic
1
2021
45
0.050
Why?
Public Health Surveillance
1
2021
61
0.040
Why?
Computer Simulation
1
2005
858
0.040
Why?
Ganciclovir
1
2000
48
0.040
Why?
Sex Factors
2
2019
1705
0.040
Why?
Adjuvants, Immunologic
2
2017
204
0.040
Why?
Africa
1
2020
92
0.040
Why?
Injections, Subcutaneous
1
2020
134
0.040
Why?
Diagnostic Tests, Routine
1
2021
86
0.040
Why?
Cost-Benefit Analysis
1
2023
542
0.040
Why?
Symptom Assessment
1
2021
119
0.040
Why?
Prevalence
2
2016
2244
0.040
Why?
Case-Control Studies
2
2019
2993
0.040
Why?
HIV Seronegativity
1
2019
24
0.040
Why?
HLA-D Antigens
1
1999
34
0.040
Why?
Longitudinal Studies
2
2017
2361
0.040
Why?
Risk
1
2021
807
0.040
Why?
Mutation
3
2018
3313
0.040
Why?
Hospitals
1
2023
582
0.040
Why?
Cytomegalovirus Infections
1
2000
175
0.040
Why?
Cholesterol, HDL
1
2019
184
0.040
Why?
Lymphocyte Culture Test, Mixed
1
1998
41
0.040
Why?
Diphtheria-Tetanus-Pertussis Vaccine
1
2018
25
0.040
Why?
Cytotoxicity Tests, Immunologic
1
1998
43
0.040
Why?
Vaccines, Combined
1
2018
46
0.040
Why?
Poliovirus Vaccine, Inactivated
1
2018
22
0.040
Why?
Odds Ratio
1
2021
953
0.040
Why?
Hepatitis B Vaccines
1
2018
46
0.040
Why?
Nutrition Surveys
1
2019
225
0.040
Why?
Drug Resistance, Microbial
2
2000
66
0.040
Why?
Reproducibility of Results
1
2005
2752
0.040
Why?
Cholesterol, LDL
1
2019
306
0.040
Why?
Case Management
1
2018
61
0.040
Why?
Cholesterol
1
2019
365
0.040
Why?
Antigens, Viral
1
1998
174
0.040
Why?
Immune Tolerance
1
1999
321
0.040
Why?
Triglycerides
1
2019
464
0.030
Why?
Epitopes, T-Lymphocyte
1
1998
170
0.030
Why?
Disease Management
1
2021
554
0.030
Why?
Treatment Adherence and Compliance
1
2017
18
0.030
Why?
Lymphocyte Count
2
2009
131
0.030
Why?
Cell Division
1
1998
745
0.030
Why?
Uncertainty
1
2017
90
0.030
Why?
Treatment Failure
1
2017
323
0.030
Why?
T-Lymphocyte Subsets
1
1998
383
0.030
Why?
Multicenter Studies as Topic
1
2017
248
0.030
Why?
Randomized Controlled Trials as Topic
1
2021
1205
0.030
Why?
Treatment Outcome
2
2021
9006
0.030
Why?
Time-to-Treatment
1
2017
146
0.030
Why?
Maternal Exposure
1
2017
138
0.030
Why?
Nevirapine
1
2015
16
0.030
Why?
Malnutrition
1
2016
62
0.030
Why?
Seroepidemiologic Studies
1
2015
137
0.030
Why?
Antiviral Agents
1
2000
635
0.030
Why?
Sexual and Gender Minorities
1
2018
140
0.030
Why?
Patient Outcome Assessment
1
2016
122
0.030
Why?
Counseling
1
2018
342
0.030
Why?
Genes, pol
1
1994
7
0.030
Why?
Coinfection
1
2016
119
0.030
Why?
Neutropenia
1
2015
122
0.030
Why?
Global Health
1
2017
287
0.030
Why?
Vaccines, Conjugate
1
2014
59
0.030
Why?
Cells, Cultured
2
2008
3802
0.030
Why?
Anemia
1
2015
141
0.030
Why?
Maternal-Fetal Exchange
1
2014
151
0.030
Why?
Severity of Illness Index
1
2021
2530
0.030
Why?
Electron Transport Complex IV
1
2013
53
0.030
Why?
Electron Transport Complex I
1
2013
33
0.030
Why?
Thrombocytopenia
1
2015
175
0.030
Why?
Radiography, Thoracic
1
2014
150
0.030
Why?
Flow Cytometry
2
2009
1065
0.030
Why?
Tuberculosis, Cutaneous
1
1993
3
0.030
Why?
HIV Reverse Transcriptase
1
1993
29
0.030
Why?
Blood Pressure
1
2019
1521
0.030
Why?
CD8 Antigens
1
1993
69
0.030
Why?
Lymphocytes
1
1994
321
0.030
Why?
CD3 Complex
1
1993
92
0.030
Why?
Oxidative Phosphorylation
1
2013
154
0.030
Why?
Drug Administration Schedule
2
2008
712
0.030
Why?
Medication Adherence
1
2017
530
0.030
Why?
Hospitalization
1
2021
1765
0.020
Why?
DNA, Mitochondrial
1
2013
181
0.020
Why?
Antigens, CD
1
1994
437
0.020
Why?
Blood Transfusion
1
1994
265
0.020
Why?
P-Selectin
1
2011
24
0.020
Why?
E-Selectin
1
2011
52
0.020
Why?
Tuberculosis, Pulmonary
1
1993
113
0.020
Why?
Heteroduplex Analysis
1
2011
1
0.020
Why?
Cell Proliferation
2
2009
2164
0.020
Why?
Chemokine CCL2
1
2011
103
0.020
Why?
Healthcare Disparities
1
2017
479
0.020
Why?
Fibrinogen
1
2011
142
0.020
Why?
Hyperlipidemias
1
2011
121
0.020
Why?
Protein Multimerization
1
2012
157
0.020
Why?
Absorptiometry, Photon
1
2011
223
0.020
Why?
Infant, Premature
1
1994
479
0.020
Why?
Cell Adhesion Molecules
1
2011
160
0.020
Why?
Cross Infection
1
1993
195
0.020
Why?
Interferon-alpha
1
2012
184
0.020
Why?
Nontuberculous Mycobacteria
1
1993
200
0.020
Why?
Diagnosis, Differential
1
2014
1328
0.020
Why?
Pokeweed Mitogens
1
2009
6
0.020
Why?
L-Selectin
1
2009
24
0.020
Why?
Human Experimentation
1
2009
12
0.020
Why?
Tetanus
1
2009
25
0.020
Why?
Candida
1
2009
32
0.020
Why?
Leukocyte Common Antigens
1
2009
72
0.020
Why?
Obesity
1
2021
2501
0.020
Why?
Multivariate Analysis
1
2011
1421
0.020
Why?
Interleukin-6
1
2011
661
0.020
Why?
Phosphorylation
1
2012
1537
0.020
Why?
Meningitis, Aseptic
1
2007
15
0.020
Why?
Virus Cultivation
1
2007
25
0.020
Why?
Pregnancy Outcome
1
2010
336
0.020
Why?
Data Interpretation, Statistical
1
2009
315
0.020
Why?
Cerebrospinal Fluid
1
2007
89
0.020
Why?
Paralysis
1
2007
66
0.020
Why?
B-Lymphocytes
1
2012
757
0.020
Why?
Multiple Organ Failure
1
2007
114
0.020
Why?
Genotype
1
2011
1733
0.020
Why?
Kinetics
1
2010
1528
0.020
Why?
CD8-Positive T-Lymphocytes
1
2011
686
0.020
Why?
Respiratory System
1
2007
137
0.020
Why?
Cell Survival
1
2009
1004
0.020
Why?
Phosphates
1
1987
154
0.020
Why?
Immunoglobulin A, Secretory
1
2005
9
0.020
Why?
Encephalitis
1
2007
125
0.020
Why?
Muscles
1
1987
313
0.020
Why?
Gastrointestinal Tract
1
2007
168
0.020
Why?
DNA-Binding Proteins
1
2012
1286
0.020
Why?
Mucous Membrane
1
2005
108
0.010
Why?
Tomography, X-Ray Computed
1
2014
2269
0.010
Why?
Middle Aged
2
2020
26552
0.010
Why?
Chemistry, Physical
1
1984
36
0.010
Why?
Antigen-Antibody Reactions
1
1984
47
0.010
Why?
Sequence Analysis, DNA
1
2007
716
0.010
Why?
Chemical Phenomena
1
1984
77
0.010
Why?
Blood Glucose
1
2013
1823
0.010
Why?
Myasthenia Gravis
1
1984
18
0.010
Why?
Aging
2
2003
1601
0.010
Why?
Body Mass Index
1
2011
1952
0.010
Why?
Saliva
1
2005
187
0.010
Why?
Immunologic Deficiency Syndromes
1
1984
61
0.010
Why?
Tissue Distribution
1
1984
280
0.010
Why?
Anti-Bacterial Agents
1
1993
1465
0.010
Why?
Epithelium
1
1984
293
0.010
Why?
Infusions, Intravenous
1
2003
368
0.010
Why?
Reference Values
1
2003
735
0.010
Why?
Mice, Inbred BALB C
1
1984
1136
0.010
Why?
Urban Population
1
2003
393
0.010
Why?
Suspensions
1
2000
30
0.010
Why?
Capsules
1
2000
36
0.010
Why?
Drug Tolerance
1
2000
77
0.010
Why?
Cytomegalovirus
1
2000
140
0.010
Why?
Signal Transduction
1
2012
4439
0.010
Why?
Epithelial Cells
1
1984
939
0.010
Why?
Administration, Oral
1
2000
719
0.010
Why?
Macrophages
1
1984
1233
0.010
Why?
Time Factors
1
2008
6032
0.010
Why?
Immunization
1
2000
397
0.010
Why?
Recombinant Proteins
1
2000
1214
0.010
Why?
Mice
1
1984
14679
0.000
Why?
Animals
2
1987
31162
0.000
Why?
Tail
1
1987
27
0.000
Why?
Phosphocreatine
1
1987
36
0.000
Why?
Salamandridae
1
1987
26
0.000
Why?
Aged
1
1984
18944
0.000
Why?
Magnetic Resonance Spectroscopy
1
1987
472
0.000
Why?
Adenosine Triphosphate
1
1987
426
0.000
Why?
McFarland's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)